Zoetis (ZTS) Net Cash Flow (2012 - 2026)
Zoetis (ZTS) reported Net Cash Flow of -$526.0 million for Q1 2026, down 44.11% year-over-year from -$941.1 million in Q1 2025, and down 326.72% quarter-over-quarter from $232.0 million in Q4 2025.
Zoetis (ZTS) Net Cash Flow (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Net Cash Flow data on file, last reported at -$526.0 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$526.0 million, down 44.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.0 million (up 138.23% YoY), and the FY2025 annual result was $286.0 million, up 1400.0% from the prior year.
- Net Cash Flow retreated to -$526.0 million in Q1 2026 per ZTS's latest filing, from $232.0 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $1.1 billion in Q4 2022 and troughed at -$1.5 billion in Q1 2023.
- A 5-year average of -$98.2 million and a median of -$127.0 million in 2022 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 385.65% in 2022 and fell as far as 17600.0% in 2022.
- A 5-year view of Net Cash Flow shows it stood at $1.1 billion in 2022, then slumped by 73.22% to $290.0 million in 2023, then decreased by 1.38% to $286.0 million in 2024, then slipped by 18.88% to $232.0 million in 2025, then sank by 326.72% to -$526.0 million in 2026.
- Business Quant data shows ZTS's Net Cash Flow at -$526.0 million in Q1 2026, $232.0 million in Q4 2025, and $644.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 139.49 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -3.97 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 32.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -526.00 Mn |
| Mar 31, 2026 | -526.00 Mn |
| Dec 31, 2025 | 232.00 Mn |
| Dec 31, 2025 | 232.00 Mn |
| Sep 30, 2025 | 644.00 Mn |
| Sep 30, 2025 | 644.00 Mn |
| Jun 30, 2025 | -225.00 Mn |
| Jun 30, 2025 | -225.00 Mn |
| Mar 31, 2025 | -365.00 Mn |
| Mar 31, 2025 | -365.00 Mn |
| Dec 31, 2024 | 286.00 Mn |
| Dec 31, 2024 | 286.00 Mn |
| Sep 30, 2024 | 145.00 Mn |
| Sep 30, 2024 | 145.00 Mn |
| Jun 30, 2024 | -393.00 Mn |
| Jun 30, 2024 | -393.00 Mn |
| Mar 31, 2024 | -60.00 Mn |
| Mar 31, 2024 | -60.00 Mn |
| Dec 31, 2023 | 290.00 Mn |
| Dec 31, 2023 | 290.00 Mn |